
Coloplast A/S
CLPBY | OTC
$6.50
+$0.03 (+0.46%)
Sep 22, 2026, 10:46 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 29, 2025 | FY 2024 Sep 29, 2024 | FY 2023 Sep 29, 2023 | FY 2022 Sep 29, 2022 | FY 2021 Sep 29, 2021 | FY 2020 Sep 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | 26.25B | 27.03B | 24.5B | 22.58B | 19.43B | 18.54B |
Cost of Revenue | 9.17B | 8.76B | 8.17B | 7.05B | 6.11B | 5.93B |
Gross Profit | 17.08B | 18.27B | 16.33B | 15.53B | 13.31B | 12.61B |
Operating Income | 7.14B | 7.32B | 6.77B | 6.44B | 6.36B | 5.85B |
Interest Income | 96.07M | 155M | 111M | 12M | 11M | 8M |
Pretax Income | 5.8B | 6.4B | 6.03B | 6.13B | 6.23B | 5.47B |
Net Income | 3.43B | 5.05B | 4.78B | 4.71B | 4.83B | 4.2B |
Selling & General & Admin | 9.1B | 10.07B | 8.63B | 7.8B | 6.25B | 6.08B |
Research & Development | 847.71M | 913M | 872M | 866M | 755M | 708M |
Other Expenses | 295K | -33M | -34M | -49M | -44M | -29M |
Operating Expenses | 9.94B | 10.95B | 9.48B | 8.62B | 6.96B | 6.76B |
Interest Expense | 777.06M | 882M | 638M | 172M | 25M | 30M |
Selling & Marketing Expenses | n/a | 8.83B | 7.52B | 6.8B | 5.49B | 5.32B |
Cost & Expenses | 19.12B | 19.71B | 17.66B | 15.67B | 13.07B | 12.69B |
Income Tax Expense | 2.38B | 1.34B | 1.24B | 1.42B | 1.41B | 1.27B |
Shares Outstanding (Basic) | 2.25B | 2.25B | 2.15B | 2.13B | 2.13B | 2.13B |
Shares Outstanding (Diluted) | 2.25B | 2.25B | 2.16B | 2.13B | 2.13B | 2.13B |
EPS (Basic) | 1.52 | 2.25 | 2.22 | 2.22 | 2.27 | 1.97 |
EPS (Diluted) | 1.52 | 2.25 | 2.22 | 2.21 | 2.26 | 1.97 |
EBITDA | 7.85B | 8.48B | 7.73B | 7.23B | 7.08B | 6.35B |
EBIT | 6.58B | 7.19B | 6.66B | 6.3B | 6.26B | 5.5B |
Depreciation & Amortization | 1.28B | 1.29B | 1.07B | 930M | 792M | 851M |
Add to Watchlist
Select watchlists to add or remove CLPBY